Building category-defining businesses
At Catalio, we invest in innovative healthcare companies at all stages and sizes, and throughout the capital structure.
Investing in breakthrough
Biotech
& beyond
[We Are]
A New York based investment firm focused on the full lifecycle of innovative healthcare investing, across private, public and credit markets.
[CATALIO]
In numbers
$1.9B
In assets under management
*as of 05/01/2025
*as of 05/01/2025
40+
Employees across offices in New York City, Washington DC, and London
45+
Venture Partners with equity interests across all Catalio strategies
[Strategy]
Overview
[Venture Partners]
Network of experts
World-renowned, serial scientist-entrepreneurs
Provide proprietary deal flow and serve as our proprietary expert network for rigorous scientific due diligence
Differentiated insight and foresight
Advise on emerging and disruptive trends in life sciences and provide early exposure to breakthrough life sciences technologies
Specialized expertise across sectors
Share nuanced perspectives on scientific and clinical value propositions
Extensive track record of success
Provide guidance as founders who have generated billions of dollars of enterprise value
See What Our
Clients Say
"
Working with Medley was a game-changer. Their team not only brought our story to life but connected with our audience in ways we hadn’t imagined. Their expertise and personal touch made all the difference.
Sophia Clarke
Marketing Director, Brightwave
-min.avif)